Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extraintestinal manifestations of inflammatory bowel disease.
Ardizzone S, Puttini PS, Cassinotti A, Porro GB. Ardizzone S, et al. Among authors: puttini ps. Dig Liver Dis. 2008 Jul;40 Suppl 2:S253-9. doi: 10.1016/S1590-8658(08)60534-4. Dig Liver Dis. 2008. PMID: 18598997 Review.
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C, Atzeni F, Spina MF, Grosso S, Cereda A, Guercilena G, Bollani S, Saibeni S, Puttini PS. Defendenti C, et al. Among authors: puttini ps. Autoimmun Rev. 2011 Jan;10(3):150-4. doi: 10.1016/j.autrev.2010.09.005. Epub 2010 Sep 18. Autoimmun Rev. 2011. PMID: 20854935 Review.
WITHDRAWN: Abatacept as a first-line biological therapy.
Caporali R, Bugatti S, Cavagna L, Antivalle M, Atzeni F, Puttini PS. Caporali R, et al. Among authors: puttini ps. Autoimmun Rev. 2013 Jun 24:S1568-9972(13)00114-6. doi: 10.1016/j.autrev.2013.06.010. Online ahead of print. Autoimmun Rev. 2013. PMID: 23806564
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next.
Mader R, Verlaan JJ, Eshed I, Bruges-Armas J, Puttini PS, Atzeni F, Buskila D, Reinshtein E, Novofastovski I, Fawaz A, Kurt V, Baraliakos X. Mader R, et al. Among authors: puttini ps. RMD Open. 2017 Jun 21;3(1):e000472. doi: 10.1136/rmdopen-2017-000472. eCollection 2017. RMD Open. 2017. PMID: 28955488 Free PMC article. Review.
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, Matucci-Cerinic M, Henes J, de Vries-Bouwstra J, Smith V, Doria A, Allanore Y, Dagna L, Anić B, Montecucco C, Kowal-Bielecka O, Martin M, Tanaka Y, Hoffmann-Vold AM, Held U, Distler O, Becker MO; EUSTAR Collaborators. Garaiman A, et al. Rheumatology (Oxford). 2023 Feb 6;62(SI):SI91-SI100. doi: 10.1093/rheumatology/keac405. Rheumatology (Oxford). 2023. PMID: 35904554
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Quartuccio L, Fabris M, Salvin S, Atzeni F, Saracco M, Benucci M, Cimmino M, Morassi P, Masolini P, Pellerito R, Cutolo M, Puttini PS, De Vita S. Quartuccio L, et al. Among authors: puttini ps. Rheumatology (Oxford). 2009 Dec;48(12):1557-9. doi: 10.1093/rheumatology/kep314. Epub 2009 Sep 29. Rheumatology (Oxford). 2009. PMID: 19789202
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.
Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y; EUSTAR collaborators. Lescoat A, et al. Rheumatology (Oxford). 2023 Jun 1;62(6):2178-2188. doi: 10.1093/rheumatology/keac576. Rheumatology (Oxford). 2023. PMID: 36222557
19 results